Cerity Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $197M | Sell |
1,639,510
-79,940
| -5% | -$9.23M | 0.28% | 71 |
|
|
2025
Q4 | $181M | Buy |
1,719,450
+9,824
| +0.6% | +$922K | 0.26% | 76 |
|
|
2025
Q3 | $143M | Sell |
1,709,626
-277,099
| -14% | -$22.8M | 0.23% | 89 |
|
|
2025
Q2 | $157M | Buy |
1,986,725
+903
| +0% | +$71.8K | 0.28% | 72 |
|
|
2025
Q1 | $178M | Buy |
1,985,822
+211,541
| +12% | +$19.8M | 0.36% | 56 |
|
|
2024
Q4 | $184M | Sell |
1,774,281
-113,531
| -6% | -$11.7M | 0.4% | 50 |
|
|
2024
Q3 | $214M | Buy |
1,887,812
+339,724
| +22% | +$40.4M | 0.47% | 38 |
|
|
2024
Q2 | $192M | Sell |
1,548,088
-258,914
| -14% | -$33.4M | 0.5% | 38 |
|
|
2024
Q1 | $239M | Buy |
1,807,002
+596,406
| +49% | +$73.5M | 0.63% | 27 |
|
|
2023
Q4 | $132M | Buy |
1,210,596
+340,073
| +39% | +$35.3M | 0.43% | 50 |
|
|
2023
Q3 | $89.8M | Sell |
870,523
-218,760
| -20% | -$23.6M | 0.44% | 52 |
|
|
2023
Q2 | $126M | Buy |
1,089,283
+61,350
| +6% | +$6.97M | 0.49% | 41 |
|
|
2023
Q1 | $124M | Buy |
1,027,933
+30,970
| +3% | +$3.34M | 0.29% | 50 |
|
|
2022
Q4 | $112M | Buy |
996,963
+501,174
| +101% | +$51.2M | 0.72% | 23 |
|
|
2022
Q3 | $42.9M | Buy |
495,789
+17,262
| +4% | +$1.54M | 0.52% | 34 |
|
|
2022
Q2 | $43.8M | Buy |
478,527
+148,931
| +45% | +$13.2M | 0.48% | 40 |
|
|
2022
Q1 | $26.5M | Sell |
329,596
-19,045
| -5% | -$1.5M | 0.41% | 54 |
|
|
2021
Q4 | $26.2M | Buy |
348,641
+23,707
| +7% | +$1.89M | 0.4% | 53 |
|
|
2021
Q3 | $24.4M | Sell |
324,934
-3,594
| -1% | -$273K | 0.54% | 39 |
|
|
2021
Q2 | $25.6M | Sell |
328,528
-8,128
| -2% | -$605K | 0.56% | 38 |
|
|
2021
Q1 | $24.8M | Buy |
336,656
+204,622
| +155% | +$15.1M | 0.59% | 37 |
|
|
2020
Q4 | $10.3M | Buy |
132,034
+28,080
| +27% | +$2.15M | 0.33% | 63 |
|
|
2020
Q3 | $8.23M | Buy |
103,954
+44,963
| +76% | +$3.52M | 0.34% | 63 |
|
|
2020
Q2 | $4.35M | Sell |
58,991
-68,974
| -54% | -$5.19M | 0.24% | 87 |
|
|
2020
Q1 | $9.4M | Buy |
127,965
+5,510
| +4% | +$433K | 0.59% | 29 |
|
|
2019
Q4 | $10.6M | Sell |
122,455
-9,474
| -7% | -$778K | 0.54% | 35 |
|
|
2019
Q3 | $10.6M | Sell |
131,929
-10,769
| -8% | -$863K | 0.62% | 34 |
|
|
2019
Q2 | $11.4M | Buy |
142,698
+68,238
| +92% | +$5.22M | 0.72% | 29 |
|
|
2019
Q1 | $5.91M | Sell |
74,460
-7,437
| -9% | -$556K | 0.4% | 50 |
|
|
2018
Q4 | $5.97M | Sell |
81,897
-1,119
| -1% | -$79K | 0.4% | 53 |
|
|
2018
Q3 | $5.62M | Sell |
83,016
-2,107
| -2% | -$134K | 0.39% | 56 |
|
|
2018
Q2 | $4.93M | Sell |
85,123
-4,899
| -5% | -$276K | 0.36% | 63 |
|
|
2018
Q1 | $4.68M | Sell |
90,022
-10,941
| -11% | -$591K | 0.36% | 67 |
|
|
2017
Q4 | $5.42M | Sell |
100,963
-808
| -0.8% | -$44.8K | 0.36% | 58 |
|
|
2017
Q3 | $6.22M | Buy |
101,771
+27,584
| +37% | +$1.67M | 0.44% | 43 |
|
|
2017
Q2 | $4.54M | Buy |
74,187
+3,459
| +5% | +$211K | 0.38% | 58 |
|
|
2017
Q1 | $4.29M | Buy |
+70,728
| New | +$4.29M | 0.36% | 53 |
|
Other funds holding MRK
VCM
VPM
Cerity Partners's MRK Position: Q1 2026 in Review
Cerity Partners reduced its Merck (MRK) stake by 4.6% in Q1 2026, selling an estimated $9.23M and leaving 1,639,510 shares worth $197M. The position accounts for 0.28% of the portfolio, ranked #71.
Cerity Partners first reported a position in MRK in Q1 2017 and has held it in 37 quarters since. The position peaked at $239M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Cerity Partners held 1,639,510 shares of Merck worth $197M as of Q1 2026.
- Cerity Partners sold 79,940 Merck shares in Q1 2026, an estimated $9.23M.
- Merck made up 0.28% of Cerity Partners's portfolio in Q1 2026, its #71 holding.
- Cerity Partners first reported a position in Merck in Q1 2017 and has held it in 37 quarters since.
- Cerity Partners's Merck position peaked at $239M in Q1 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.